Purevax FeLV RSS Authorised This medicine is authorised for use in the European Union vaccine against feline leukaemia Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Purevax FeLV Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Purevax FeLV : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 13/02/2008 Last updated: 19/12/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View español (ES) (81.97 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View čeština (CS) (93.99 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View dansk (DA) (83.34 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View français (FR) (82.44 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View íslenska (IS) (83.29 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View italiano (IT) (82.29 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View magyar (HU) (94.15 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Malti (MT) (95.95 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View norsk (NO) (82 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View polski (PL) (95.62 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View português (PT) (83.01 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View română (RO) (94.17 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Suomi (FI) (81.54 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View svenska (SV) (82.05 KB - PDF) First published: 13/02/2008 Last updated: 19/12/2024 View Product information Purevax FeLV : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 23/10/2007 Last updated: 19/12/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View español (ES) (81.51 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View čeština (CS) (92.48 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View dansk (DA) (82.05 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View français (FR) (81.63 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View íslenska (IS) (81.52 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View italiano (IT) (81.76 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View magyar (HU) (92.76 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Malti (MT) (93.86 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View norsk (NO) (81.52 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View polski (PL) (93.22 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View português (PT) (82.53 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View română (RO) (91.73 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Suomi (FI) (81.11 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View svenska (SV) (81.47 KB - PDF) First published: 23/10/2007 Last updated: 19/12/2024 View Latest procedure affecting product information: Purevax FeLV : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 19/10/2007 Last updated: 19/12/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View español (ES) (81.97 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View čeština (CS) (93.99 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View dansk (DA) (83.34 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View français (FR) (82.44 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View íslenska (IS) (83.29 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View italiano (IT) (82.29 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View magyar (HU) (94.15 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Malti (MT) (95.95 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View norsk (NO) (82 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View polski (PL) (95.62 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View português (PT) (83.01 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View română (RO) (94.17 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Suomi (FI) (81.54 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View svenska (SV) (82.05 KB - PDF) First published: 19/10/2007 Last updated: 19/12/2024 View Product details Name of medicine Purevax FeLV Active substance feline leukaemia virus recombinant canarypox virus (vCP97) International non-proprietary name (INN) or common name vaccine against feline leukaemia Pharmacotherapeutic groupImmunologicals for felidae Authorisation details EMA product number EMEA/V/C/000056 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Purevax FeLV : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 19/11/2008 Last updated: 19/12/2024 View Initial marketing authorisation documents Purevax FeLV : EPAR - Scientific Discussion English (EN) (81.49 KB - PDF)First published: 23/10/2007 Last updated: 19/12/2024 View Purevax FeLV : EPAR - Procedural steps taken before authorisation English (EN) (15.34 KB - PDF)First published: 22/11/2005 Last updated: 22/11/2005 View News on Purevax FeLV Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 May 202025/05/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 201820/04/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 February 201816/02/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 June 201716/06/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 April 201718/04/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 4-6 November 201407/11/2014 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 March 201414/03/2014 Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 12-14 January 201015/01/2010 Topics Medicines This page was last updated on 19/12/2024 Share this page